The Delft University of Technology has awarded Prof. Frederik Beekman to be the most entrepeneurial scientist of 2010. The jury was unanimous in their choice and very impressed by the way in which Beekman translates his knowledge into technology that directly contributes to improving pre-clinical diagnostics.
The Frost & Sullivan Best Practices team has presented MILabs with the 2010 New Product Innovation Award for VECTor. In their analysis MILabs is recognized as a rapidly growing company standing out among the players in the Preclinical Imaging market with world-class products. MILabs’ proprietary VECTor technology provides fully integrated simultaneous SPECT and PET imaging with sub-mm resolution. In numerous molecular imaging applications VECTor surpasses the resolution capabilities of both classical coincidence PET and competing SPECT technologies.
A new device combines high-resolution PET with SPECT scanners to allow scientists working on cancer and brain research with small animals to see functional details down to a half millimeter in size.
Dubbed the Versatile Emission Computed Tomography, or VECTor, this device, developed by researchers at the Delft University of Technology in the Netherlands and the company Molecular Imaging Labs, could help scientists find cancer treatments.
Highest resolution SPECT in the world now available with integrated X-ray CT.
MILabs introduces U-SPECT/CT, the highest resolution ultra-sensitive SPECTsystem which is fully integrated with a high throughput, low dose CT scanner. For the first time sub-half-mm resolution, ultra-fast dynamic and multi-channel molecular imaging capabilities can be readily combined with anatomical X-ray CT information obtained with low dose.
An attractive aspect of high resolution integrated U-SPECT/CT is that the bed with animal does not have to be moved from one scanner to another. U-SPECT is field upgradable to U-SPECT/CT.
Press release: TU Delft and MILabs merge PET and SPECT biomedical imaging techniques and deliver increased resolution
TU Delft and MILabs merge PET and SPECT biomedical imaging techniques and deliver increased resolution
TU Delft and Molecular Imaging Labs (MILabs) have succeeded in combining two forms of medical imaging techniques into one piece of equipment. These techniques are particularly useful for cancer research. The two techniques are known as microPET and microSPECT. SPECT and PET can be performed simultaneously and they give a higher resolution than traditional microSPECT and microPET. The new device is known as the VECTor (Versatile Emission Computed Tomography) and is designed for use in fundamental research into the functioning of cells and organs. It can show functional details smaller than half a millimetre.
Dutch researchers using preclinical imagers U-SPECT from MILabs of Utrecht, The Netherlands, and Inveon PET from Siemens Healthcare of Knoxville TN, said the imaging methods allowed them to successfully and noninvasively visualize the insulinlike growth factor 1 receptor among animal subjects with triple-negative breast cancer. Being able to image the receptor could improve patient selection from the triple-negative breast cancer patient population for targeted treatment using IGF-1R antibodies, an expert said.
For more information see the Full article at AuntMinnie.com (free registration)
NGP gathers industry experts of Cisbio, MILabs, PerkinElmer and Roche to discuss the current drug development space. Prof. Beekman, CEO/CSO Milabs states that drug development can, and needs to become, much faster and effective by using novel tools that facilitate early selection of potentially successful drug lea
MILabs introduces a novel tool U-Overlay™ which allows fast field-of-view selection. Using an anatomic overlay the position of organs is clearly projected over optical images of the animal. Apart from the convenience it can result in shorter and more accurate scans since pinholes are more focused to your area of interest. This allows you to acquire huge amounts of counts from very specific structures.